The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tenzer, S.
Right arrow Articles by Schild, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tenzer, S.
Right arrow Articles by Schild, H.
The Journal of Immunology, 2004, 172: 1083-1091.
Copyright © 2004 by The American Association of Immunologists

Quantitative Analysis of Prion-Protein Degradation by Constitutive and Immuno-20S Proteasomes Indicates Differences Correlated with Disease Susceptibility1

Stefan Tenzer*, Lars Stoltze{ddagger}, Birgitt Schönfisch{dagger}, Jörn Dengjel*, Margret Müller*, Stefan Stevanovic*, Hans-Georg Rammensee* and Hansjörg Schild2,*,§

* Department of Immunology, Institute for Cell Biology, and {dagger} Biomathematics, University of Tübingen, Tübingen, Germany; {ddagger} Medical Research Council Prion Unit, Department of Neurodegenerative Diseases, Institute of Neurology, University of London, London, United Kingdom; and § Institute for Immunology, University of Mainz, Mainz, Germany

The main part of cytosolic protein degradation depends on the ubiquitin-proteasome system. Proteasomes degrade their substrates into small peptide fragments, some of which are translocated into the endoplasmatic reticulum and loaded onto MHC class I molecules, which are then transported to the cell surface for inspection by CTL. A reliable prediction of proteasomal cleavages in a given protein for the identification of CTL epitopes would benefit immensely from additional cleavage data for the training of prediction algorithms. To increase the knowledge about proteasomal specificity and to gain more insight into the relation of proteasomal activity and susceptibility to prion disease, we digested sheep prion protein with human constitutive and immuno-20S proteasomes. All fragments generated in the digest were quantified. Our results underline the different cleavage specificities of constitutive and immunoproteasomes and provide data for the training of prediction programs for proteasomal cleavages. Furthermore, the kinetic analysis of proteasomal digestion of two different alleles of prion protein shows that even small changes in a protein sequence can affect the overall efficiency of proteasomal processing and thus provides more insight into the possible molecular background of allelic variations and the pathogenicity of prion proteins.




This article has been cited by other articles:


Home page
J. Virol.Home page
N. J. Steers, K. K. Peachman, S. R. McClain, C. R. Alving, and M. Rao
Human Immunodeficiency Virus Type 1 Gag p24 Alters the Composition of Immunoproteasomes and Affects Antigen Presentation
J. Virol., July 15, 2009; 83(14): 7049 - 7061.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
I. Ginodi, T. Vider-Shalit, L. Tsaban, and Y. Louzoun
Precise score for the prediction of peptides cleaved by the proteasome
Bioinformatics, February 15, 2008; 24(4): 477 - 483.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
C. Lundegaard, O. Lund, C. Kesmir, S. Brunak, and M. Nielsen
Modeling the adaptive immune system: predictions and simulations
Bioinformatics, December 15, 2007; 23(24): 3265 - 3275.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Webb, T. Lekishvili, C. Loeschner, S. Sellarajah, F. Prelli, T. Wisniewski, I. H. Gilbert, and D. R. Brown
Mechanistic Insights into the Cure of Prion Disease by Novel Antiprion Compounds
J. Virol., October 1, 2007; 81(19): 10729 - 10741.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Ninkovic and F.-G. Hanisch
O-Glycosylated Human MUC1 Repeats Are Processed In Vitro by Immunoproteasomes
J. Immunol., August 15, 2007; 179(4): 2380 - 2388.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. M. Asemissen, U. Keilholz, S. Tenzer, M. Muller, S. Walter, S. Stevanovic, H. Schild, A. Letsch, E. Thiel, H.-G. Rammensee, et al.
Identification of a Highly Immunogenic HLA-A*01-Binding T Cell Epitope of WT1
Clin. Cancer Res., December 15, 2006; 12(24): 7476 - 7482.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Osterloh, K. Linkemann, S. Tenzer, H.-G. Rammensee, M. P. Radsak, D. H. Busch, and H. Schild
Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses
PNAS, March 28, 2006; 103(13): 5042 - 5047.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Milicic, D. A. Price, P. Zimbwa, B. L. Booth, H. L. Brown, P. J. Easterbrook, K. Olsen, N. Robinson, U. Gileadi, A. K. Sewell, et al.
CD8+ T Cell Epitope-Flanking Mutations Disrupt Proteasomal Processing of HIV-1 Nef
J. Immunol., October 1, 2005; 175(7): 4618 - 4626.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. K. Nussbaum, M. P. Rodriguez-Carreno, N. Benning, J. Botten, and J. L. Whitton
Immunoproteasome-Deficient Mice Mount Largely Normal CD8+ T Cell Responses to Lymphocytic Choriomeningitis Virus Infection and DNA Vaccination
J. Immunol., July 15, 2005; 175(2): 1153 - 1160.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Halliday, F. Houston, and N. Hunter
Expression of PrPC on cellular components of sheep blood
J. Gen. Virol., May 1, 2005; 86(5): 1571 - 1579.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.